Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
2021246 citationsJournal Articlebronze Open Access
Field-Weighted Citation Impact: 15.09
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial | Researchclopedia